medigraphic.com
ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2013, Number 6

<< Back Next >>

Salud Mental 2013; 36 (6)

Comorbilidad de los trastornos por consumo de sustancias con otros trastornos psiquiátricos en Centros Residenciales de Ayuda-Mutua para la Atención de las Adicciones

Marín-Navarrete R, Benjet C, Guilherme Borges, Eliosa-Hernández A, Nanni-Alvarado R, Ayala-Ledesma M, Fernández-Mondragón J, Medina-Mora ME

Language: Spanish
References: 35
Page: 471-479
PDF size: 291.96 Kb.


ABSTRACT

Substance use disorders have a high degree of comorbidity with other psychiatric disorders; it has been reported that the prevalence of comorbidity is higher in psychiatric (20-50%) and addiction (50-75%) treatment settings than in household or student populations. Because of limited treatment alternatives and greater treatment needs, Mutual- Aid groups have become relevant in the last decades. A modality of Mutual-Aid for addiction treatment that has proliferated in Mexico has taken the form of residential Mutual-Aid centers called “anexos” in Spanish. The objective of this study was to estimate the prevalence of lifetime comorbidity between substance use disorders and psychiatric disorders in those who attended these residential Mutual-Aid centers. The initial sample consisted of 535 male participants diagnosed with a substance use disorder, but only 346 fulfilled the inclusion criteria to continue with the evaluation. Only males were included as the participating centers only admit males. Psychiatric diagnosis was evaluated with the Composite International Diagnostic Interview (WMH-CIDI) using DSM-IV criteria. The results showed that 75.72% met criteria for any comorbid psychiatric disorder, the most frequent being attention deficit and conduct disorders, followed by anxiety disorders, separation anxiety disorders, mood disorders, impulse control disorders and least frequently eating disorders. While the study is limited by its nonrepresentative sample, the findings provide valuable information for a hidden population for which there is a dearth of information and points to the need for integrative services which address both addiction and comorbid psychiatric disorders simultaneously.


REFERENCES

  1. Medina-Mora ME, Natera G, Borges G, Cravioto P et al. Del siglo XX al tercer milenio. Las adicciones y la salud pública: drogas, alcohol y sociedad. Salud Mental 2001;24:3-19.

  2. Daley D, Moss H. Dual disorder: Counseling clients with chemical dependency and mental illness. Tercera edición.) Minnesota: Hazelden; 2002.

  3. Substance Abuse and Mental Health Services Administration (SAMHSA). Report to congress on the prevention and treatment of cooccurring substance abuse disorders and mental disorders. Inventory number: BKD467; 2002.

  4. Substance Abuse and Mental Health Services Administration (SAMHSA) and Center for Substance Abuse Center (CSAT). Substance abuse treatment for persons with co-occurring disorders. Treatment improvement protocol Vol. 42. [DHHS Publication No. (SMA) 05-3992]; 2005.

  5. Regier DA, Farmer ME, Rae DS, Locke BZ et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. JAMA 1990;264(19):2511-2518.

  6. World Health Organizations. The world health report 2001. Metal Health: New Understanding, New Hope. Ginebra: 2001.

  7. Levounis P, Galanter M, Dermatis H, Hamowy A et al. Correlates of HIV transmission risk factors and considerations for interventions in homeless, chemically addicted and mentally ill patients. J Addictive Diseases 2002;61-72.

  8. Lukasiewicz M, Blecha L, Falissard BXN, Benyamina A et al. Dual diagnosis: Prevalence, risk factors, and relationship with suicide risk in a nationwide sample of French prisioners. Alcoholism: Clinical Experimental Research 2009;160-168.

  9. Young DS. Co-occurring disorders among jail inmates: Bridging the treatment gap. J Social Work Practice Addictions 2000;63-85.

  10. Slesnick N, Prestopnik J. Dual and multiple diagnosis among substance using runaway youth. American J Drug Alcohol Abuse 2005;179- 201.

  11. Newmann JP, Sallman J. Women, trauma histories, and co-occurring disorders: Assessing the scope of the problem. Social Service Review 2004;466-499.

  12. Rush B, Koegl CJ. Prevalence and Profile of People with Co-occurring Mental and Substance Use Disorders within a Comprehensive Mental Health System. Canadian Journal of Psychiatry, 2008;810-821.

  13. Swadi H, Bobier C. Substance use disorder comorbidity among inpatient youths with psychiatric disorder. Australian New Zealand J Psychiatry, 2003;294-298.

  14. Nocon A, Bergé D, Astals M, Martín-Santos R et al. Dual diagnosis in an inpatient drug-abuse detoxification unit. European Addiction Research 2007;192-200.

  15. Watkins KE, Hunter SB, Wenzel SL, Tu W et al. Prevalence and characteristics of clients with co-occurring disorders in outpatient substance abuse treatment. American J Drug Alcohol Abuse 2004;749-764.

  16. Fabricius V, Langa M, Wilson K. An exploratory investigation of cooccurring substance related and psychiatric disorders. J Substance Use 2008;99-114.

  17. Hasin D, Nunes E, Meylan J. Comorbidity of alcohol, drug and psychiatric disorders: Epidemiology. En: Kranzler H, Tinsley J. Dual diagnosis and psychiatric treatment: Substance abuse and comorbid disorders. USA: Segunda edición; Marcel Bekker; 2004; pp. 1-34.

  18. Drake RE, Wallach MA. Dual diagnosis: 15 Years of Progress. Psychiatric Services 51(9):1126-1129.

  19. Sacks S, Sacks J, De Leon G, Bernhardt AI et al. Modified therapeutic community for mentally ill Chemicals “abusers”: Background; influences; program description; preliminary findings. Substance Use Misuse 1997;32(9):1217–1225.

  20. Brunette MF, Mueser KT, Drake RE. A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders. Drug Alcohol Review 2004;23:471-481.

  21. Drake RE, Mueser KT, Brunette MF, McHugo GJ. A Review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatric Rehabilitation J, 2004;27(4):360-374.

  22. Caraveo-Anduaga JJ, Colmenares-Bermúdez E. Los trastornos psiquiátricos y el abuso de sustancias en México: Panorama epidemiológico. Salud Mental 2002;25(2):9-15

  23. Díaz-Martínez LR, Campillo Serrano C, Cerrud-Sánchez J, Rosado- Franco A et al. El consumo de alcohol en la población psiquiátrica. Anales. Instituto Mexicano de Psiquiatría, Reseña de la VII Reunión de Investigación: 1992;108-116.

  24. Díaz-Martínez LR. Comorbilidad psiquiátrica: consumo excesivo de alcohol y trastornos psiquiátricos. Las Adicciones: hacia un enfoque multidisciplinario. México: Secretaría de Salud; 1994.

  25. Marín-Navarrete R, Eliosa-Hernández A, Lozano-Verduzco I, Fernández- De la Fuente C et al. Estudio sobre la experiencia de hombres atendidos en centros residenciales de ayuda mutua para la atención de las adicciones. Salud Mental 2013;36(59):393-402

  26. Pulido-Rull MA, Moyers-González M, Martínez-Salas A. Algunos datos acerca del funcionamiento de una muestra de grupos de autoayuda en México. Revista Mexicana de Investigación en Psicología, 2009;1(1):85-97.

  27. American Psychiatric Association.APA. DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders. Washington, DC. Cuarta edición revisada; 2000.

  28. Apiquian R, Páez F, Tapia RO, Fresán A. Validez y confiabilidad de la Escala para la Evaluación de la Manía. Salud Mental 1997;20(3):23-29.

  29. Colom F, Vieta E, Martínez-Arán A, García-García M et al. 2002; Versión española de una escala de evaluación de la manía: validez y fiabilidad de la escala de Young. Med Clin Barcelona 1997;119:366-371.

  30. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatr 1978;133:429-435.

  31. Becerra B, Ortega-Soto HA, Torner C. Validez y reproductibilidad del examen cognoscitivo breve (Mini-mental State Examination) en una unidad de cuidados especiales de un hospital psiquiátrico. Salud Mental 1992;15(4):41-45.

  32. Folstein MF, Folstein SE, Mc Hugh PR et al. 1975; Minimental state: a practical guide for grading the cognitive state of patients for the clinician. J Psychiatric Res 1992;12:189-198.

  33. Kessler y Üstün, 2004; http://www.hcp.med.harvard.edu/wmh/

  34. Haro JM, Arbabzadeh-Bouchez S, Brugha TS, De Girolamo G et al. Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health Surveys. International Jf Methods Psychiatric Research 2006;15:167–180.

  35. Medina-Mora ME, Borges G, Lara C, Benjet C et al. Prevalence, service use, and demographic correlates of 12-month DSM-IV psychiatric disorders in Mexico: results from the Mexican National Comorbidity Survey. Psychological Medicine 2005;35:1-11.




2020     |     www.medigraphic.com